To investigate whether DPP4 expression is correlated with clinical outcomes, we analyzed DPP4 expression and CRC progression based on the data from 98 CRC patients at Catalan Institute of Oncology.[26] The patients were divided into two cohorts, DPP4high and DPP4low. This evidence concerns the gene DPP4 and colorectal carcinoma.